CS logo
small CS logo
Coffs Habour Health Campus - NCCI

Coffs Harbour, New South Wales, Australia

About Coffs Habour Health Campus - NCCI


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Coffs Habour Health Campus - NCCI


During the past decade, Coffs Habour Health Campus - NCCI conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Coffs Habour Health Campus - NCCI" #1 collaborator was "National Health and Medical Research Council, Australia" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Central and Eastern European Oncology Group" with 1 trials as a collaborator and "Chinese Thoracic Oncology Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

Clinical Trials Conditions at Coffs Habour Health Campus - NCCI


According to Clinical.Site data, the most researched conditions in "Coffs Habour Health Campus - NCCI" are "Lung Cancer Metastatic" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Unresectable/Metastatic Melanoma" (1 trials). Many other conditions were trialed in "Coffs Habour Health Campus - NCCI" in a lesser frequency.

Clinical Trials Intervention Types at Coffs Habour Health Campus - NCCI


Most popular intervention types in "Coffs Habour Health Campus - NCCI" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Continuous PD-1 inhibitor therapy" (1 trials), "Durvalumab" (1 trials), "Intermittent PD-1 inhibitor therapy" (1 trials), "MEDI4736" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Coffs Habour Health Campus - NCCI


The vast majority of trials in "Coffs Habour Health Campus - NCCI" are 3 trials for "All" genders.

Clinical Trials Status at Coffs Habour Health Campus - NCCI


Currently, there are NaN active trials in "Coffs Habour Health Campus - NCCI". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Coffs Habour Health Campus - NCCI, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Coffs Habour Health Campus - NCCI, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".